Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Specific Aim: Implement an evidence-based diabetes prevention pragmatic trial for high risk
pre-diabetic individuals of Caribbean-descent to reduce the incidence of diabetes.
Hypothesis: This study seeks to test the hypothesis that implementation of a lifestyle
intervention, with escalation to Metformin therapy will lower the incidence of diabetes among
the highest risk pre-diabetic individuals of Caribbean-descent.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institute on Minority Health and Health Disparities (NIMHD)